Cancer

Pembrolizumab promising for metastatic head, neck SCC

(HealthDay)—For patients with recurrent or metastatic head and neck squamous cell carcinoma, pembrolizumab has a favorable safety profile and is associated with prolongation of overall survival, according to a study published ...

Cancer

Pembrolizumab not better than PTX for advanced gastric cancer

(HealthDay)—For patients with previously treated advanced gastric cancer or gastro-esophageal junction cancer, pembrolizumab does not result in a significant improvement in overall survival compared with paclitaxel, according ...

page 1 from 3